Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
10:30 - 11:30
K11
Functional biomarkers and prediction models 1
Anne Kiltie, United Kingdom;
Laura Rechner, Denmark
Poster Discussions
Physics
10:30 - 11:30
Conventional to ultra-hypofractionated prostate cancer radiotherapy: Does the dose to the internal anal sphincter nerve predict late bowel symptoms?
Christian Jongen, The Netherlands
-2793
10:30 - 11:30
Externally validating radiation pneumonitis radiomics signatures in chemoradio-immunotherapy for locally advanced Non Small Cell Lung Cancer
Maria Thor, USA
-4417
10:30 - 11:30
External validation of an FDG-PET-radiomic model for distant-relapse-free-survival after radio-chemotherapy for pancreatic adenocarcinoma
Monica Maria Vincenzi, Italy
-2681
10:30 - 11:30
Multigrade prediction model for xerostomia following radiotherapy in head and neck cancer
Emmy Dalqvist, Sweden
-2051
10:30 - 11:30
A compartment model predicting lymphocyte depletion using patient-specific radiosensitivity
Takahiro Kanehira, Japan
-811
10:30 - 11:30
Piecewise dose-response relationship between mean heart dose and risk of cardiac troponin elevation
Ting Xu, USA
-1186
10:30 - 11:30
Normal tissue complication probability modeling of temporal lobe radionecrosis using delivered versus planned dose in skull base proton therapy.
Bastien Golomer, Switzerland
-2710
10:30 - 11:30
Nested cross-validation with systematic multicollinearity management for predictive modeling of radionecrosis in stereotactic radiosurgery
Karen Manger, Germany
-777
10:30 - 11:30
An interpretable multimodal radiopathomics model predicting pCR to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.
Zhen Zhang, China
-2563
10:30 - 11:30
Feasibility Study on Prognostic Risk of Rectal cancer: AI Model-Extracted pathological features After Neoadjuvant Chemoradiotherapy
Jiazhou Wang, China
-1967